Lab Testing Memberships: 100 Biomarkers, Then What?

TL;DR: Lab testing memberships draw your blood, test 50 to 160 things, and show the results in an app. That data can help. What the membership usually does not include is a doctor who treats you. Someone still has to decide which flags matter, order the next test, and write the prescription. Before you subscribe, know that many of the same tests can be run through your insurance for less. If you already have results, do not sit alone with a scary dashboard: bring the PDF to a physician who will read the whole thing with you.

The pitch has gotten very good. For a few hundred dollars a year, a membership tests you top to bottom, twice a year, and shows every biomarker on a dashboard with green and red zones. Some wearable companies now sell the same idea as an add-on, so the ring or band that scores your sleep can also draw your blood.

I want to be fair to these services, because the impulse behind them is one I built my practice on: you want to see problems coming, and the standard 8-test annual physical was never going to show you. Testing ApoB, Lp(a), fasting insulin, and a full thyroid panel is the kind of medicine I practice. The panels are not the problem.

The problem is what the fine print says happens after the blood draw.

What does the membership include after the results post?

Read the terms of any lab membership or wearable blood panel closely and a pattern appears. A licensed clinician signs the lab order, reviews results, and contacts you about values in a dangerous range. The dashboard generates insights and general suggestions. And treatment, the medicine itself, is explicitly not part of the product: for anything that needs a diagnosis, a workup, or a prescription, you are directed back to your own doctor.

That is a reasonable legal structure, and the safety review matters. But notice what it means for you. You have purchased observation. The service can tell you that your ApoB is 115 mg/dL and color it red. It cannot examine you, weigh that number against your family history, order the follow-up imaging, prescribe the medication, or watch what the number does over the next 5 years. The half of medicine that changes outcomes was never in the box.

What can 100 biomarkers not tell you?

More testing feels like more certainty, and sometimes it is. A wide panel run on a large number of healthy people also produces predictable trouble, and knowing the trouble in advance is the difference between using these tools and being used by them.

Statistical noise reads as red flags. Every lab range is built so that about 5% of healthy results fall outside it. Test 100 biomarkers and the average healthy person shows 4 or 5 flags by arithmetic alone. Without a clinician sorting signal from noise, each flag becomes a week of worry or a rabbit hole of supplements aimed at a number that was never a problem.

A value without a trend is a photograph of a moving object. A ferritin of 45, a TSH of 4.2, a fasting glucose of 101: each means something different depending on where it was last year and where it goes next. Dashboards are starting to plot trends, but interpreting a trajectory against your history, your medications, and your symptoms is clinical work.

The panel cannot ask you a single question. The most important diagnostic tool in medicine is still the story. Night sweats, a new snore, a father's heart attack at 52, a period that changed, none of it appears in a blood panel, and any one of those can matter more than 20 biomarkers.

Data without an exam misses what hands and ears catch. A thyroid nodule, a heart murmur, an enlarged liver edge, a blood pressure that runs high at home and behaves at the draw site. Blood work was never designed to stand alone.

Cancer screening is not in there. Broad blood panels are metabolic, hormonal, and cardiovascular. Colonoscopy, mammography, low-dose CT for eligible smokers, skin checks, and cervical screening still do the cancer-screening work, on the schedule your age and risk set.

Should you buy the membership, or order the labs another way?

Sometimes the membership is the right call, and I say that as a physician with no stake in the answer. If the subscription is what gets you a first baseline after years of skipped physicals, it has done something your last 5 physicals did not.

Before you pay, know your alternatives. Most of the marquee biomarkers on these panels (ApoB, Lp(a), fasting insulin, homocysteine, a full thyroid panel, hormone levels) are ordinary tests at Quest or LabCorp that a physician can order with insurance billing, which for many patients brings the cash price near zero. The affordable labs guide explains how we do that with zero markup at Fishtown Medicine. The wearable-linked panels have one genuine edge: the same app holds your sleep, activity, and recovery data, and blood work read next to your sleep and training data is better than blood work alone. I use that pairing in practice, with the important difference that a physician is doing the reading.

If you already subscribed, keep the subscription doing what it is good at and add the missing half. Download the full PDF report, not screenshots, and bring it to a physician who will treat it as the start of your chart. That is how I use these reports in practice: confirm which flags matter, set the noise aside out loud so it stops costing you sleep, order what the results point to next, and fold it all into a plan that gets re-tested on a schedule chosen for your biology. Members here do this so often that the practice keeps a standing playbook for handing over outside lab data, whether it came from a membership panel, a wearable add-on, or a named service like Function Health.

Related at Fishtown Medicine

• Function Health in Philadelphia: You Have the Data. Now What? - the named-service version of this playbook.
• The Affordable Labs Guide - how advanced biomarkers get ordered with zero markup.
• Executive Physicals in Philadelphia - the full-picture alternative.
• Should You Upload Your Labs to AI? - the other thing people do with a confusing PDF.
• The Longevity Library - what we do with biomarkers once we have them.

Scientific References

1. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology. 2019;4(12):1287-1295.
2. Tsimikas S. A Test in Context: Lipoprotein(a). Journal of the American College of Cardiology. 2017;69(6):692-711.
3. Welch HG, Schwartz LM, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Beacon Press; 2011.
4. Whiting PF, Davenport C, Jameson C, et al. How well do health professionals interpret diagnostic information? A systematic review. BMJ Open. 2015;5:e008155.